Mutation in KERA Identified by Linkage Analysis and Targeted Resequencing in a Pedigree with Premature Atherosclerosis

• Stephanie Maiwald ,

  Contributed equally to this work with: Stephanie Maiwald, Suthesh Sivapalaratnam, Mahdi M. Motazacker, Willem H. Ouwehand, Geesje M. Dallinga-Thie, G. Kees Hovingh

  Affiliations Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands, Department of Experimental Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands

  ⨯
• Suthesh Sivapalaratnam ,

  Contributed equally to this work with: Stephanie Maiwald, Suthesh Sivapalaratnam, Mahdi M. Motazacker, Willem H. Ouwehand, Geesje M. Dallinga-Thie, G. Kees Hovingh

  Affiliation Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands

  ⨯
• Mahdi M. Motazacker ,

  Contributed equally to this work with: Stephanie Maiwald, Suthesh Sivapalaratnam, Mahdi M. Motazacker, Willem H. Ouwehand, Geesje M. Dallinga-Thie, G. Kees Hovingh

  Affiliation Department of Experimental Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands

  ⨯
• Julian C. van Capelleveen,

  Affiliation Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands

  ⨯
• Ilze Bot,

  Affiliations Division of Biopharmaceutics, Leiden/Amsterdam Centre for Drug Research, Leiden, the Netherlands, Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, United Kingdom

  ⨯
• Saskia C. de Jager,

  Affiliations Division of Biopharmaceutics, Leiden/Amsterdam Centre for Drug Research, Leiden, the Netherlands, Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, United Kingdom

  ⨯
• Miranda van Eck,

  Affiliations Division of Biopharmaceutics, Leiden/Amsterdam Centre for Drug Research, Leiden, the Netherlands, Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, United Kingdom

  ⨯
• Jennifer Jolley,

  Affiliations Department of Haematology, University of Cambridge, Cambridge, United Kingdom, National Health Service Blood and Transplant, Cambridge, United Kingdom

  ⨯
• Johan Kuiper,

  Affiliations Division of Biopharmaceutics, Leiden/Amsterdam Centre for Drug Research, Leiden, the Netherlands, Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, United Kingdom

  ⨯
• Jonathon Stephens,

  Affiliations Department of Haematology, University of Cambridge, Cambridge, United Kingdom, National Health Service Blood and Transplant, Cambridge, United Kingdom

  ⨯
• Cornelius A. Albers,

  Affiliations Department of Haematology, University of Cambridge, Cambridge, United Kingdom, National Health Service Blood and Transplant, Cambridge, United Kingdom

  ⨯
• C. Ruben Vosmeer,

  Affiliation Amsterdam Institute of Molecules, Medicines and Systems, Division of Molecular and Computational Toxicology, Department of Chemistry and Pharmaceutical Sciences, VU University, Amsterdam, the Netherlands

  ⨯
• Heleen Kruize,

  Affiliation Amsterdam Institute of Molecules, Medicines and Systems, Division of Molecular and Computational Toxicology, Department of Chemistry and Pharmaceutical Sciences, VU University, Amsterdam, the Netherlands

  ⨯
• Daan P. Geerke,

  Affiliation Amsterdam Institute of Molecules, Medicines and Systems, Division of Molecular and Computational Toxicology, Department of Chemistry and Pharmaceutical Sciences, VU University, Amsterdam, the Netherlands

  ⨯
• Allard C. van der Wal,

  Affiliation Department of Pathology, Academic Medical Centre, Amsterdam, the Netherlands

  ⨯
• Chris M. van der Loos,

  Affiliation Department of Pathology, Academic Medical Centre, Amsterdam, the Netherlands

  ⨯
• John J. P. Kastelein,

  Affiliation Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands

  ⨯
• Mieke D. Trip,

  Affiliation Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands

  ⨯
• Willem H. Ouwehand ,

  Contributed equally to this work with: Stephanie Maiwald, Suthesh Sivapalaratnam, Mahdi M. Motazacker, Willem H. Ouwehand, Geesje M. Dallinga-Thie, G. Kees Hovingh

  Affiliations Department of Haematology, University of Cambridge, Cambridge, United Kingdom, National Health Service Blood and Transplant, Cambridge, United Kingdom

  ⨯
• Geesje M. Dallinga-Thie ,

  Contributed equally to this work with: Stephanie Maiwald, Suthesh Sivapalaratnam, Mahdi M. Motazacker, Willem H. Ouwehand, Geesje M. Dallinga-Thie, G. Kees Hovingh

  * E-mail: g.k.hovingh@amc.nl (GKH); g.m.dallinga@amc.nl (GMD)

  Affiliations Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands, Department of Experimental Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands

  ⨯
•  [ ... ],
• G. Kees Hovingh

  Contributed equally to this work with: Stephanie Maiwald, Suthesh Sivapalaratnam, Mahdi M. Motazacker, Willem H. Ouwehand, Geesje M. Dallinga-Thie, G. Kees Hovingh

  * E-mail: g.k.hovingh@amc.nl (GKH); g.m.dallinga@amc.nl (GMD)

  Affiliation Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands

  ⨯
• [ view all ]
• [ view less ]